Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04646174 · ClinicalTrials.gov registry record · NA
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start-II Study
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT04646174 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 66 participants.
The verdict
NCT04646174, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Chronic Obstructive Pulmonary Disease (COPD) is caused primarily by smoking and smoking cessation is the first-line treatment for slowing disease progression. Despite this, nearly 50% of COPD patients continue to smoke following diagnosis. Smokers with COPD report high rates of co-occurring conditions - nicotine dependence, depression, and anxiety - which serve as barriers to quitting. The current study will pilot test a behavioral intervention designed to target the common psychological factors underlying these co-occurring conditions and foster smoking cessation among COPD patients.
Interventions
- BEHAVIORAL Unified Protocol adapted for smoking cessation
- BEHAVIORAL American Lung Association self-management strategies for smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04646174
The ClinicalTrials.gov registry entry for NCT04646174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Unified Protocol adapted for smoking cessation is the first listed.
NCT04646174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04646174 about?
NCT04646174 is a clinical study titled "Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start-II Study". Chronic Obstructive Pulmonary Disease (COPD) is caused primarily by smoking and smoking cessation is the first-line treatment for slowing disease progression. Despite this, nearly 50% of COPD patients continue to smoke following diagnosis. Smokers with COPD report high rates of co-occurring conditio...
What is the current status of trial NCT04646174?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2020-12-14. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04646174?
The interventions under investigation include: Unified Protocol adapted for smoking cessation (BEHAVIORAL), American Lung Association self-management strategies for smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04646174?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.